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Background: Antidiabetic activity of Derris reticulata extract on alloxan-induced diabetic rats has been reported.
The extract was found to lower blood glucose and inhibit intestinal glucose absorption. The aim of this study was
to further investigate mechanisms underlying the antihyperglycemic activity of D. reticulata extract in vitro.
Methods: The aqueous extract was obtained from D. reticulata stem. Phytochemical screening, total phenolic, and
flavanoid contents were examined. ABTS and DPPH scavenging assays, and FRAP method were used to determine
in vitro antioxidant activities. Measurement of cell viability on alloxan-induced cellular damage was performed in
the insulin-secreting RINm5F cells by MTT assay. The effects of the extract on α-glucosidase activity and insulin
release were studied. In addition, sub-chronic toxicity test in rats was also conducted.
Results: The results revealed that the extract, which consisted of terpenoids, saponins, tannins and flavonoids,
possessed moderate radical scavenging activities. Pre-treatment of RINm5F cells with the extract was also found to
exert moderate, but significant, in vitro protection against alloxan, an oxidative stress producing agent. Unlike
glibenclamide, the extract did not stimulate insulin secretion. However, the extract was found to inhibit α-glucosidase
activity similar to acarbose. It was found that in sub-chronic toxicity studies D. reticulata extract did not cause mortality
or produce any remarkable haematological, biochemical and histopathological adverse effects in rats.
Conclusions: The data suggest that the possible mechanisms underlying antihyperglycemic activity of D. reticulata
extract are cytoprotective effect on pancreatic cells, presumably by its antioxidant activity, and inhibition of
α-glucosidase. Sub-chronic toxicity study also provides scientific evidence to corroborate the safety of this plant as an
alternative antidiabetic agent.
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Diabetes mellitus is a chronic metabolic disease charac-
terized by hyperglycemia resulting from reduction of in-
sulin secretion and/or insulin resistance. It is widely
known that elevation of blood glucose caused by disrup-
tion of carbohydrate, protein and fat metabolism can
lead to diabetic complications in several organs and tis-
sues, including eyes, kidneys, nerves and blood vessels
[1]. It has been shown that current therapy for diabetes
with synthetic hypoglycemic agents can produce adverse* Correspondence: nuannoi@sut.ac.th
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unless otherwise stated.effects such as hypoglycemia, gastrointestinal distur-
bances and hepatotoxicity [2]. Therefore, the search for
herbal formulation with antidiabetic activity remains a
topic of research interest.
Plants from diverse families have been shown to pos-
sess potent hypoglycemic activities [3]. Thus, several
plants have been used as an alternative treatment in pa-
tients with diabetes [4]. In Thailand, the use of trad-
itional medicine plays an important role in public health
care and many medicinal plants have been used to treat
several ailments including diabetes [5]. In our previous
report, the efficacy of the aqueous extract of Derris
reticulata stems, a local plant used by some rural
Thais to treat diabetes, has been demonstrated inl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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further investigated antioxidant activity of D. reticulata
extract to support its cytoprotective potential. The effects
of the extract on α-glucosidase activity and insulin re-
lease were studied. In addition, sub-chronic toxicity test
was also conducted to establish the safety of the extract
in rats.
Methods
Collection of plant material and extraction
Plant collection and extraction were performed as previ-
ously described by our group [6]. Briefly, small pieces of
dried stem (100 g) were boiled twice with 500 ml of dis-
tilled water for 10 min each. After filtered through cot-
ton gauze, the filtrate was centrifuged at 2,500 × g for
10 min. Supernatant was collected and lyophilized. The
dried extract (yield 16.73%, w/w) was kept at −20°C
until used. Authenticity of the plant was verified by
Dr. Paul J. Grote and the voucher specimen (Pharm-
Chu-006) was deposited at School of Pharmacology,
Suranaree University of Technology (SUT).
Phytochemical screening
Phytochemical screening was carried out to identify con-
stituents of D. reticulata extract. The extract was screened
for anthraquinones, terpenoids, flavonoids, saponins, tan-
nins and cardiac glycosides. Phytochemical screening was
performed based on previously reported methods [7,8].
Determination of antioxidant compounds
Determination of total phenolic content
The phenolic compounds of the D. reticulata extract
was determined by a method previously described [9].
D. reticulata extract (5 mg) was dissolved in 1 ml of dis-
tilled water. A 100 μl of aliquot was mixed with 2 ml of
2% Na2CO3. The mixture was left standing for 2 min at
room temperature followed by an addition of 100 μl of
Folin-Ciocalteau reagent (diluted with methanol 1:1 v/v).
After incubation for 30 min, absorbance was measured
at 750 nm using spectrophotometer. Gallic acid was
used for standard curve calibration. Total phenolic con-
tent of D. reticulata extract was expressed as mg gallic
acid equivalents (GAE) per gram extract.
Determination of total flavonoid content
Total flavonoid content was measured according to the
method reported by Liu and coworkers [10]. In brief,
250 μl of D. reticulata extract (5 mg/ml) was diluted
with 1250 μl of distilled water. 75 μl of a 5% NaNO2 so-
lution was added to the mixture and incubated for
6 min. After the incubation period, 150 μl of 10% AlCl3
solution was added. The mixture was further incubated
for 5 min. Then, 500 μl of 1 M NaOH was added, and
the final volume was adjusted to 2500 μl with distilledwater. The absorbance was measured at 510 nm and
compared to standard catechin. Total flavonoid content
of D. reticulata extract was expressed as mg catechin
per gram extract.
Determination of antioxidant activities
ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonate)
scavenging assay
The radical scavenging activity of D. reticulata extract
against ABTS•+ was carried out according to the proced-
ure described previously [11]. Briefly, ABTS•+ radical
cation was produced by mixing 5 ml of 14 mM ABTS
with 5 ml of 4.9 mM potassium persulphate (K2S2O8)
for 16 h in the dark at room temperature. Before used,
the ABTS•+ solution was diluted with ethanol to an ab-
sorbance of 0.70 ± 0.02 at 734 nm. A various concentra-
tions (50 μl) of D. reticulata extract was mixed with
950 μl of diluted ABTS•+ solution. After 6 min of incu-
bation, the absorbance was read at 734 nm. Butylated
hydroxytoluene (BHT) was used as standard. The anti-
oxidant activity was expressed as IC50 (the concentration
required for 50% scavenging of free radical).
DPPH (2,2-diphenyl-1-picrylhydrazyl) scavenging assay
The ability of the D. reticulata extract to scavenge DPPH
free radical was measured according to the procedure de-
scribed previously [12] with slight modifications. A various
concentrations (1 ml) of the D. reticulata extract were
added to 4 ml of DPPH methanolic solution (final concen-
tration of DPPH: 0.2 M). The reaction mixture was shaken
and left standing at room temperature for 30 min in the
dark and then spectroscopically measured at 517 nm. The
antioxidant activity was expressed as IC50 similar to the
ABTS scavenging method.
Ferric reducing antioxidant power (FRAP) assay
The ferric reducing power of the extract was performed
according to the procedure described previously [13].
FRAP reagent consists of 10 mM TPTZ solution (2,4,6-
tripyridyl-s-triazine) in 40 mM HCl, 20 mM FeCl3, and
300 mM acetate buffer (pH 3.6), in ratio 1:1:10 (v/v/v),
respectively. FRAP reagent was freshly prepared and in-
cubated at 37°C until used. The reaction mixtures were
composed of 50 μl of D. reticulata extract (5 mg/ml)
mixed with 1.5 ml of the FRAP reagent. After 4 min, the
absorbance was measured at 593 nm. The reducing po-
tential of the D. reticulata extract was determined from
a standard curve of FeSO4 and the FRAP value was
expressed as μmol Fe2+/mg dried extract.
Determination of cell viability on alloxan-induced
cellular damage
RINm5F, Rattus norvegicus (rat) cell line was obtained
from the American Type Culture Collection (ATCC,
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1640 medium supplemented with 10% fetal bovine
serum, 1% antibiotic-antimycotic solution and incubated
at 37°C in a humidified atmosphere containing 5% CO2.
RINm5F cells (2 × 105) were incubated with D. reticu-
lata extract for 23 h. After the incubation period, the
medium was removed. Cells were treated with alloxan at
9 mM (which caused about 50% of cell death) for 1 h.
At the end of experiment, cell viability was assessed by
MTT assay as previously described [14].
Determination of α-glucosidase inhibitory effect
The α-glucosidase inhibitory activity was measured as
described previously [15] with minor changes. The crude
enzyme solution was prepared from Saccharomyces
cerevisiae Type I (Sigma–Aldrich, USA). The reaction
mixture consisted of crude enzyme solution (0.1 U/ml,
10 μl), in 0.1 M potassium phosphate buffer pH 6.8
(50 μl), and the test sample (20 μl). Acarbose (Bayer,
Indonesia) was used as positive control. After pre-
incubation at 37°C for 10 min, 10 μl of 1 mM p-nitro-
phenyl-α-D-glucopyranoside (Sigma–Aldrich, USA) was
added. The solution was incubated for an additional
30 min at 37°C. The reaction was terminated by adding
50 μl of 0.1 M Na2CO3. At the end of incubation, the
absorbance was measured at 405 nm. The concentra-
tion of inhibitors required for inhibiting 50% of the
α-glucosidase activity under the assay conditions was
defined as the IC50 value.
Determination of the effect on insulin secretion
The insulin secretion assay was performed according
to the previously described method [16]. RINm5F cells
(2 × 105 cells/well) were seeded in 96 well plates and
grown to reach 70-80% confluent state. Culture medium
was removed and replaced with Kreb’s Ringer buffer.
After 60 min of incubation, cells were washed twice with
fresh Kreb’s Ringer buffer and then incubated with the
D. reticulata extract at 250 and 500 μg/ml, and gliben-
clamide (50 μg/ml) for 60 min. The extract was diluted
with Kreb’s Ringer buffer. Glibenclamide was dissolved
in DMSO and further diluted with Kreb’s Ringer buffer.
The final concentration of DMSO (0.5% w/v) did not
affect RINm5F cell viability. The supernatant was col-
lected for measurement of insulin release by enzyme-
linked immunosorbent assay (ELISA).
Sub-chronic toxicity study
Male and female Wistar rats used in this study were ob-
tained from Laboratory Animal Center, SUT. Animals
were acclimatized for 7 days prior to the experiments.
The rats were housed in polypropylene cages, with free
access to normal diet and water ad libitum. The rats
were maintained at room temperature (25 ± 0.5°C),relative humidity 45-50% and at 12 h light/dark cycle.
All procedures in this study were approved and con-
ducted according to guidelines of the Institutional Animal
Care and Use Committee, SUT. All efforts were made to
minimize the number of rats used and their suffering.
Wistar rats of both sexes were randomly assigned into
five groups, a control and four treatment groups (n = 8;
4 males and 4 females). The treatment groups were
given the extract 250, 500, 1000 and 2000 mg/kg by oral
route once a day for 42 days. The body weights were re-
corded at the end of each week. All animals were ob-
served daily for clinical signs and mortality throughout
the treatment period. At the end of treatment, rats were
fasted overnight for 14 h. All rats were anesthetized by
CO2 inhalation and blood samples were immediately
collected via cardiac puncture for haematological and
biochemical analyses. After blood collection, the rats
were sacrificed by cervical dislocation. Internal organs
were excised, weighed, and examined macroscopically.
The relative organ weight was calculated as (organ
weight/body weight) × 100%. Vital organs such as
liver and kidney were preserved for histopathological
examinations.
Haematological and biochemical evaluations
Haematological analysis was determined using a blood
autoanalyzer Coulter (Beckman Coulter Inc., Ireland).
The measured haematological parameters included: red
blood cell (RBC), white blood cell (WBC), lymphocyte
(LYM), monophil (MON), eosinophil (EOS), basophil
(BAS), platelet cell (PLT), haemoglobin (HGB), haemato-
crit (HCT), mean corpuscular volume (MCV), mean
corpuscular haemoglobin (MCH) and mean corpuscular
haemoglobin concentration (MCHC).
For biochemical parameters analysis, blood sample
without anticoagulant was centrifuged at 3,000 × g for
5 min to obtain serum. Serum was stored at −20°C until
analysis. The serum was analysed by A15 Analyzer
Automatic Clinical Chemistry (Biosystems S.A., Spain).
Biochemical parameters assessed included: glucose, total
cholesterol, triglyceride, creatinine, aspartate transamin-
ase (AST), alanine transaminase (ALT).
Histopathological examinations
Tissue samples of liver and kidney were fixed with 10%
neutral buffered formaldehyde and dehydrated in serial
ethanol solution (70%, 95% and 100%) and acetone. Tis-
sue samples were cleaned with xylene. The tissues were
infiltrated with molten paraffin at 65°C and embedded in
paraffin block and sectioned at 5 μm thickness. The sec-
tions were mounted onto slides using gelatin coating so-
lution and dried at 56°C for 45 min in a hot air oven.
Tissue sections were deparaffined in xylene and were hy-
drated with serial ethanol solution (100%, 95% and 70%).
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stained with haematoxylin for 10 min and washed in
running tap water. The sections were stained with eosin
for 10 min, followed by dehydrated with serial ethanol
solution (70%, 95% and 100%). Finally, the sections
were immersed in acetone and xylene and covered
with cover slip after drying. The photomicrographs of
each tissue section were observed under microscope
(Olympus, Japan).
Statistical analysis
Data are expressed as mean ± S.E.M. Comparisons
among different groups were performed by analysis of
variance (ANOVA) followed by Student-Newman-Keuls
test. P-values less than 0.05 were set as the level of
significance.
Results
Phytochemical compositions, phenolic content and total
flavonoid content
The extract of D. reticulata stem obtained from this
study contained terpenoids, flavonoids, saponins and
tannins but not anthraquinones and cardiac glycosides.
Total phenolic content and total flavonoid content found
in D. reticulata extract were 78.84 ± 0.01 mg GAE/g ex-
tract and 54.72 ± 1.81 mg catechin/g extract, respectively.
Antioxidant activity of D. reticulata extract
It has been demonstrated that in vitro analytical
methods are reliable determination of antioxidant activ-
ity of biological sample. However, it has been recom-
mended that assays based on hydrogen atom transfer
and electron transfer reaction together should be used
to provide a better view of antioxidant activity than a
single method [17]. Accordingly, in this study, three ana-
lysis methods including ABTS radical scavenging, DPPH
radical scavenging and ferric reducing antioxidant power
(FRAP) assays were performed to determine and confirm
antioxidant activity of D. reticulata extract. As shown
in Table 1, the IC50 of ABTS radical scavenging ac-
tivity of the extract was found at 515.05 ± 0.13 μg/ml,
whereas that of DPPH scavenging activity was atTable 1 Antioxidant activities of Derris reticulata extract
Methods
ABTS DPPH FRAP
(IC50: μg/ml) (IC50: μg/ml) (μmol Fe
2+/mg
dried extract)
Derris reticulata extract 515.05 ± 0.13 239.85 ± 0.13 0.23 ± 0.05
Ascorbic acid - 1.23 ± 0.18 -
Butylated hydroxytoluene
(BHT)
83.05 ± 0.13 - -
Values are expressed as means ± S.E.M. (n = 3).239.85 ± 0.13 μg/ml. In addition, the FRAP value of the
extract was 0.23 ± 0.05 μmol Fe2+/mg dried extract.
In vitro cytoprotective effect of the extract
The protective effect of D. reticulata extract against
alloxan-induced cell death was studied by MTT assay.
The half maximal inhibitory concentration (9 mM) of
alloxan on cell viability was used for studying the cyto-
protective effect of the extract. It was found that alloxan,
a free radical producing agent, decreased the number of
RINm5F cells and altered their morphology as well as
caused cell detachment from plate (Figure 1A). In ac-
cordance with microscopic observation, the result from
MTT assay (Figure 1B) showed that pretreatments of
D. reticulata extract provided a significant protection
effect from alloxan-induced RINm5F cell damage. The
extract increased cell viability from 50.25 ± 0.30 up to
78.51 ± 0.29%. Note that the concentration of the extract
was limited at 500 μg/ml to avoid toxicity on cell viabil-
ity that may be caused by the extract itself.
Inhibitory effect of D. reticulata extract on α-glucosidase
activity
Several concentrations (250–5000 μg/ml) of D. reticulata
extract were tested to determine levels of α-glucosidase
inhibition. It was found that D. reticulata extract inhibited
α-glucosidase activity in dose-dependent manner with the
IC50 of 917.29 ± 0.13 μg/ml, whereas the IC50 of acarbose
(positive control) was 1378.99 ± 0.13 μg/ml (Figure 2). The
maximal inhibition of the extract reached approximately
92% similar to that of acarbose.
Effect of D. reticulata extract on insulin secretion
RINm5Fcells were used to evaluate the effect of D. reti-
culata extract on insulin secretion in vitro and the data
were shown in Figure 3. The insulin secretagogue glib-
enclamide significantly increased insulin concentration
in the medium from 1.35 ± 0.04 to 2.36 ± 0.15 ng/105
cells compared to control. It was found that unlike glib-
enclamide, the extract at the doses of 250 and 500 μg/ml
did not significantly alter insulin secretion from RINm5F
cells.
Sub-chronic toxicity
Clinical observation, body weight and relative organ weight
Sub-chronic administration of D. reticulata extract did
not produce clinical signs of toxicity. The body weight in-
creased throughout the study period in male and female
rats of both control and treated groups. The patterns of
water and food consumption were similar in all groups of
animals. No lethality was observed during the 42-day
period of treatment with D. reticulata extract. There
were no significant changes in the relative organ weight
Figure 1 Cytoprotective effect of D. reticulata extract on cell viability. Panel (A) is microscopic images (200×) of RINm5F cells whereas Panel
(B) is the effect on % cell viability measured by MTT assay. Pre-treatment with D. reticulata extract was performed on alloxan-induced RINm5F cell
damage. The IC50 of alloxan (9 mM) was used to induce cell death after pre-treatment with various concentrations of the extract. In panel (A), A
is normal control whereas B is cells treated with alloxan alone. The cells in panels C-H were treated with the extract at 50, 100, 150, 200, 250 and
500 μg/ml, respectively, for 23 hours before exposure of alloxan. Values in Panel (B) are expressed as mean ± S.E.M. (n = 3). * p < 0.05 statistically
significant difference compared to control. # p < 0.05 statistically significant difference compared to alloxan (ALX).
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ous doses as compared to the control group.
Haematological and biochemical parameters
Haematological parameters of male and female rats
depicted in Tables 2 and 3 showed that the number of
red blood cells and white blood cells of treatment groups
were not significantly different from the control group.
However, the number of platelets of all treated female
rats significantly increased (Table 2) while male rats
treated with D. reticulata extract at 250 mg/kg had a
significant decrease of MCH (Table 3). However, this ef-
fect was not dose dependent because it was not found in
the groups treated with 500, 1000 and 2000 mg/kg of
D. reticulata extract. There were significant differences
(p < 0.05) in MCV and MCHC between the treated and
the control groups in male rats. More importantly, it
should be noted that all of the parameters in treatedgroups that were different compared to control are
within the normal ranges. Biochemical parameter pro-
files of male and female rats are presented in Table 4.
Oral administration of D. reticulata extract did not cause
significant changes in the level of glucose, total cholesterol,
triglyceride, creatinine, AST and ALT. All biochemical pa-
rameters analyzed were within the normal laboratory
ranges. Thus the extract did not cause abnormality in the
haematological and biochemical parameters of rats.
Histopathological examinations
There was no macroscopic change of internal organs
(i.e., appearance, color, size) considered to be related
to the treatment. The histopathological examinations
of liver and kidney revealed no morphological alter-
ation in all treatment and control groups. Representative
photomicrographs of liver and kidney were shown in
Figure 4.
Figure 2 Inhibitory effect of D. reticulata extract on α-glucosidase
activity. Values are expressed as mean ± S.E.M. of three separate
experiments. Acarbose was used as positive reference. The calculated
IC50 of the extract was 918 ± 172 μg/ml whereas that of acarbose
was 1379 ± 17 μg/ml.
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Phenolic compounds are secondary metabolites of
plants, which widely distributed throughout the plant
kingdom. Phenolics are gaining attention because their
antioxidant activities have shown health benefits [18,19].
Plant phenolics have exhibited health protective effects
in many ailments, for example inflammation, cancer and
hypertension [20]. The antioxidant activity of plant ma-
terials is well correlated with their content of phenolic
compounds [21,22].
In this study, the phytochemical qualitative screening
tests revealed that D. reticulata extract consisted of
terpenoids, flavonoids, saponins and tannins but notFigure 3 Effect of D. reticulata extract on insulin secretion. Glibenclam
1.35 ± 0.04 (control) to 2.36 ± 0.15 ng/105 cells. Treatment with the extract
secretion from RINm5F cells (1.27 ± 0.09 and 1.38 ± 0.09 ng/105 cells, respec
statistically significant difference from control.anthraquinones and cardiac glycosides. Lupinifolin which
is a flavonoid compound has been found to be a major
compound of D. reticulata Craib. [23]. Phytochemical
studies of other plants in Derris genus have been reported.
For example, two pyranoflavanones, epoxylupinifolin and
dereticulatin isolated from the stem of D. reticulata Benth.
were identified [24]. Furanoflavanoids were also isolated
from D. indica [25] whereas the study of D. laxiflora
has revealed that it contains some triterpenoids [26]. Scan-
denin A, scandenin B and isoflavone derivatives have been
found in D. scandens [27,28].
Total phenolic content determined by Folin-Ciocalteu
method was 78.84 ± 0.01 mg GAE/g extract. Antioxidant
compounds of D. reticulata extract presumably were
tannins and flavonoids found in preliminary phytochem-
ical analysis. Total flavonoid content in the extract, as
measured by aluminium chloride colorimetric method
was 54.72 ± 1.81 mg catechin/g extract. Several studies
have reported that flavonoids possess antioxidant prop-
erty [29,30]; and the hydroxyl groups in flavonoids are
responsible for the free radical scavenging activity of
these compounds [31].
ABTS radical scavenging, DPPH radical scavenging
and ferric reducing antioxidant power (FRAP) assays
were performed to determine the antioxidant activity of
D. reticulata extract. As shown in Table 1, the IC50 of
ABTS radical scavenging activity of the extract was
515.05 ± 0.13 μg/ml, whereas that of DPPH scavenging
activity was 239.85 ± 0.13 μg/ml. In addition, the FRAP
value of the extract was 0.23 ± 0.05 μmol Fe2+/mg dried
extract. Together, the results indicate that D. reticulata
extract possessed a moderate degree of radical scaven-
ging activities.
The aqueous extract of D. reticulata stem was previ-
ously reported to possess potential antidiabetic property
in rats [6]. The phytochemical analysis of the aqueouside significantly increased insulin concentration in the medium from
at the doses of 250 and 500 μg/ml did not significantly alter insulin
tively). Values are expressed as mean ± S.E.M. (n = 3). * p < 0.05
Table 2 Haematological parameters of female rats administered with Derris reticulata extract for 42 days
Parameters Control Treatment
250 mg/kg 500 mg/kg 1000 mg/kg 2000 mg/kg
Female
RBC (×106/μl) 8.10 ± 0.17 7.94 ± 0.32 8.21 ± 0.19 8.12 ± 0.15 8.40 ± 0.16
HGB (g/dl) 16.00 ± 0.00 15.50 ± 0.65 16.25 ± 0.25 16.00 ± 0.00 16.75 ± 0.25
HCT (%) 45.50 ± 0.65 43.25 ± 2.10 44.00 ± 0.71 44.50 ± 0.87 45.00 ± 0.82
WBC (×103/μl) 1.33 ± 0.25 5.18 ± 2.26 1.08 ± 0.40 1.35 ± 0.35 1.58 ± 0.11
LYM (%) 86.25 ± 0.95 87.50 ± 3.40 76.25 ± 4.63 82.25 ± 4.84 88.50 ± 1.04
MON (%) 2.00 ± 0.41 3.50 ± 1.56 2.00 ± 0.71 1.75 ± 1.11 0.75 ± 0.48
EOS (%) 2.25 ± 0.85 1.00 ± 1.00 5.50 ± 4.27 3.50 ± 2.22 1.50 ± 0.29
BAS (%) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
PLT (103/μl) 618.5 ± 43.1 811.8 ± 34.8* 807.3 ± 49.0* 818.8 ± 43.3* 752.8 ± 45.2*
MCV (fl) 56.00 ± 0.58 54.43 ± 0.80 53.78 ± 0.60 54.80 ± 0.46 53.63 ± 0.29
MCH (pg) 19.75 ± 0.40 19.68 ± 0.20 19.63 ± 0.34 19.78 ± 0.14 19.60 ± 0.06
MCHC (g/dl) 35.28 ± 0.55 36.10 ± 0.27 36.50 ± 0.27 36.08 ± 0.27 36.55 ± 0.25
Values are expressed as mean ± S.E.M. (n = 4/group).
*p < 0.05 statistically significant difference from control.
Note that all of the parameters in treated groups that were different compared to control are within the normal ranges.
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constituents which could have potential antidiabetic
property as shown in some other herbs. For example, it
has been reported that Solanum torvum Swartz extract
containing phenolic compounds (rutin, caffeic acid,
gallic acid and catechin) exhibits hypoglycemic activity
and is known for their ability to promote β-cell regener-
ation [32]. Flavonoids and triterpenoids, the two major




RBC (×106/μl) 9.15 ± 0.21 9.55 ± 0.11
HGB (g/dl) 17.75 ± 0.25 17.50 ± 0.29
HCT (%) 52.50 ± 1.56 50.25 ± 0.63
WBC (×103/μl) 1.48 ± 0.28 5.58 ± 1.84
LYM (%) 83.50 ± 2.96 75.50 ± 5.72
MON (%) 3.25 ± 2.02 3.25 ± 1.11
EOS (%) 0.25 ± 0.25 0.50 ± 0.29
BAS (%) 0.00 ± 0.00 0.00 ± 0.00
PLT (103/μl) 731.3 ± 45.3 863.0 ± 44.5
MCV (fl) 57.10 ± 0.58 52.63 ± 0.37*
MCH (pg) 19.25 ± 0.24 18.35 ± 0.10*
MCHC (g/dl) 33.65 ± 0.30 34.88 ± 0.17*
Values are expressed as mean ± S.E.M. (n = 4/group).
*p < 0.05 statistically significant difference from control.
Note that all of the parameters in treated groups that were different compared to cextract have protective effects on β-cells in diabetic rats
[30]. As shown in Figure 1, pre-treatments with D. reti-
culata extract at the doses of 50–500 μg/ml provided
a significant protective effect from alloxan-induced
RINm5F cell death. It is known that alloxan induces dia-
betes mellitus by generating free radical, resulting in its
toxic action on pancreatic β-cells [33,34]. In accordance
with its moderate antioxidant activity found in this
study, pretreatment of D. reticulata extract increasedwith Derris reticulata extract for 42 days
500 mg/kg 1000 mg/kg 2000 mg/kg
8.56 ± 0.24 8.82 ± 0.28 8.80 ± 0.16
16.50 ± 0.50 17.25 ± 0.63 16.75 ± 0.25
47.00 ± 1.68 48.00 ± 2.12 47.00 ± 0.91
4.50 ± 1.43 3.80 ± 0.38 2.15 ± 0.70
85.00 ± 2.48 85.50 ± 1.66 82.50 ± 5.12
2.75 ± 1.44 2.75 ± 0.85 2.00 ± 1.00
0.75 ± 0.25 0.50 ± 0.29 0.75 ± 0.75
0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
638.8 ± 35.7 667.8 ± 21.4 798.8 ± 43.5
54.90 ± 0.38* 54.30 ± 0.86* 53.45 ± 0.43*
19.40 ± 0.14 19.18 ± 0.18 19.03 ± 0.11
35.38 ± 0.29* 35.28 ± 0.26* 35.63 ± 0.36*
ontrol are within the normal ranges.
Table 4 Biochemical parameters of male and female rats administered with Derris reticulata extract for 42 days
Parameters Control Treatment
250 mg/kg 500 mg/kg 1000 mg/kg 2000 mg/kg
Male
Glucose (mg/dl) 125.8 ± 10.4 114.3 ± 10.7 135.8 ± 5.1 114.0 ± 2.0 118.5 ± 4.3
Total cholesterol (mg/dl) 61.50 ± 2.60 52.75 ± 3.50 61.50 ± 4.52 44.50 ± 2.84 50.75 ± 5.82
Triglyceride (mg/dl) 80.75 ± 18.44 85.50 ± 6.61 81.75 ± 13.83 76.75 ± 6.16 93.75 ± 23.02
Creatinine (mg/dl) 0.78 ± 0.09 0.65 ± 0.03 0.69 ± 0.04 0.68 ± 0.01 0.67 ± 0.04
AST (U/l) 96.25 ± 7.39 96.00 ± 6.49 99.00 ± 9.46 95.00 ± 10.98 98.00 ± 8.37
ALT (U/l) 32.75 ± 4.27 28.25 ± 3.64 33.25 ± 2.93 25.50 ± 2.72 29.25 ± 3.09
Female
Glucose (mg/dl) 101.0 ± 8.2 91.00 ± 2.1 104.5 ± 7.0 101.8 ± 7.0 83.75 ± 4.4
Total cholesterol (mg/dl) 53.00 ± 2.80 45.50 ± 3.20 45.75 ± 4.64 44.25 ± 1.49 42.25 ± 5.47
Triglyceride (mg/dl) 40.50 ± 10.21 47.25 ± 3.50 52.25 ± 14.63 35.75 ± 2.87 47.75 ± 7.12
Creatinine (mg/dl) 0.74 ± 0.06 0.83 ± 0.06 0.73 ± 0.04 0.74 ± 0.07 0.76 ± 0.02
AST (U/l) 93.75 ± 6.21 86.00 ± 5.87 88.00 ± 7.36 75.00 ± 5.45 86.00 ± 4.06
ALT (U/l) 24.25 ± 2.50 35.25 ± 13.33 23.75 ± 1.55 19.25 ± 0.48 23.00 ± 1.47
Values are expressed as mean ± S.E.M. (n = 4/group).
There was no significant difference among control and treatment groups (p > 0.05).
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that the cytoprotective effect of D. reticulata extract
against alloxan may be partly derived from the free rad-
ical scavenging activity of its antioxidant compounds.
Uncontrolled hyperglycemia in diabetic patients is as-
sociated with profound complications, such as increased
risk of coronary heart disease, peripheral vascular dis-
ease, and cerebrovascular disease [1]. The reduction of
postprandial hyperglycemia has been approached byFigure 4 Representative photomicrographs of liver and kidney of ma
D. reticulata. A: Liver control; B: Liver of animal treated with 2000 mg/kg e
extract. Hematoxylin and eosin staining (200×).suppression of carbohydrate absorption from gastrointes-
tinal tract [35]. Several plant extracts have been shown to
exert antidiabetic property through α-glucosidase inhib-
ition, for example, the aqueous extract of Ficus deltoidea
[22], the acetone leaf extracts of F. lutea [36] and the
hydro-alcoholic extracts of Polygonum senegalensis and
P. kotschyi [37]. In addition to the interference of intes-
tinal glucose absorption as previously reported [6], it was
found in the present study that D. reticulata extractle and female rats after administered with the aqueous extract of
xtract; C: Kidney control; D: Kidney of animal treated with 2000 mg/kg
Kumkrai et al. BMC Complementary and Alternative Medicine  (2015) 15:35 Page 9 of 10also inhibited α-glucosidase in vitro with the IC50 of
918 ± 172 μg/ml, whereas the IC50 of acarbose, an antidi-
abetic drug known to inhibit intestinal α-glucosidase, was
1379 ± 17 μg/ml (Figure 2). This action should contribute
to the anti-hyperglycemic effect of the extract. The result
also suggests that the extract may be clinically useful for
the control of postprandial hyperglycemia.
RINm5F cells have been used for studying the effect of
insulin secretagogues. In this study, the insulin concen-
trations of the cell culture supernatant were determined.
Glibenclamide, an insulin secretagogue, was selected as
positive control. Glibenclamide stimulates insulin secre-
tion by blocking ATP-sensitive potassium channels of
the β-cell membrane, thereby causing depolarization
calcium influx, and rising in cytoplasmic calcium con-
centration [38]. RINm5F cells treated with glibenclamide
showed a significant increase in insulin secretion
(Figure 3). In contrast, D. reticulata extract at the
doses of 250 and 500 μg/ml did not possess a stimulatory
effect on insulin release. This result suggests that the ex-
tract may have some advantages over glibenclamide or
other insulin secretagogues in terms of causing fewer
clinical events of hypoglycemia.
Because diabetes mellitus is a chronic metabolic dis-
ease which requires long term treatment, its safety data
for long term use is crucial. Therefore, sub-chronic tox-
icity of D. reticulata extract was evaluated in rats for
42 days. The extract at the doses of 250, 500, 1000 and
2000 mg/kg did not affect body weight of the treated
animals compared to control. Animal behaviors were
also observed and the extract did not produce any signs
of behavioral toxicity. Organ weight changes have long
been accepted as a sensitive indicator of chemically in-
duced organ alterations. It was found that the extract
did not induce any changes in relative organ weight.
Several haematological and biochemical parameters were
analyzed. There were no significant changes of all tested
parameters to the toxic level (Tables 2, 3, 4). Histopatho-
logical observation on liver and kidney of both control
and treatment groups revealed that sub-chronic oral ad-
ministration of the extract did not cause any alteration
of organ morphology (Figure 4). The results indicate that
the aqueous extract of D. reticulata do not cause mortal-
ity or produce any remarkable haematological, biochem-
ical and histopathological adverse effects in sub-chronic
toxicity studies in rats.
Conclusion
The present study has demonstrated that D. reticulata
extract exerts antihyperglycemic activity by cytoprotective
effect on pancreatic cells, probably via its antioxidant activ-
ity, and inhibition of the enzyme α-glucosidase. This study
also provides sub-chronic toxicity data to corroborate clin-
ical use of this plant as an alternative antidiabetic agent.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PK performed the experiments, analyzed/interpreted data and wrote the
manuscript. OV contributed to analyzed/interpreted data and assisted the
manuscript writing. NC contributed to the concept, designed experiments,
analyzed/interpreted data and finalized the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This investigation was financially supported by SUT Research and Development
Fund (12/2556). We thank Dr. Paul J. Grote for verification of plant botanical
classification.
Author details
1School of Pharmacology, Institute of Science, Suranaree University of
Technology, Nakhon Ratchasima 30000, Thailand. 2School of Anatomy,
Institute of Science, Suranaree University of Technology, Nakhon Ratchasima
30000, Thailand. 3Current address: Division of Health Promotion, Faculty of
Health Science, Srinakharinwirot University, Ongkharak, Nakhon-Nayok 26120,
Thailand.
Received: 21 October 2014 Accepted: 13 February 2015
References
1. Schlienger JL. Type 2 diabetes complications. Presse Med. 2013;42(5):839–48.
2. Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral
antidiabetic drugs. Expert Opin Drug Saf. 2013;12(2):153–75.
3. Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic
medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed.
2012;2(4):320–30.
4. Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilar-Contreras A,
Contreras-Weber CC, Flores-Saenz JL. Study of the anti-hyperglycemic effect
of plants used as antidiabetics. J Ethnopharmacol. 1998;61(2):101–10.
5. Wiwanitkit V. Thai ethnopharmacological herbs for diabetes treatment: data
collection and informatics tracing for therapeutic property. Diabetes Metab
Syndr. 2011;5(2):103–4.
6. Kumkrai P, Kamonwannasit S, Chudapongse N. Cytoprotective and anti-
diabetic effects of Derris reticulata aqueous extract. J Physiol Biochem.
2014;70(3):675–84.
7. Ayoola GA, Coker HAB, Adesegun SA, Adepoju-Bello AA, Obaweya K,
Ezennia EC, et al. Phytochemical screening and antioxidant activities of
some selected medicinal plants used for malaria therapy in southwestern
Nigeria. Trop J Pharm Res. 2008;7(3):1019–24.
8. Yadav A, Agarwala M. Phytochemical analysis of some medicinal plants.
J Phytol. 2011;3(12):10–4.
9. Matthaus B. Antioxidant activity of extracts obtained from residues of
different oilseeds. J Agric Food Chem. 2002;50(12):3444–52.
10. Liu M, Li XQ, Weber C, Lee CY, Brown J, Liu RH. Antioxidant and antiproliferative
activities of raspberries. J Agric Food Chem. 2002;50(10):2926–30.
11. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant
activity applying an improved ABTS radical cation decolorization assay. Free
Radic Biol Med. 1999;26(9–10):1231–7.
12. Bor JY, Chen HY, Yen GC. Evaluation of antioxidant activity and inhibitory
effect on nitric oxide production of some common vegetables. J Agric
Food Chem. 2006;54(5):1680–6.
13. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure
of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239(1):70–6.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival:
application to proliferation and cytotoxicity assays. J Immunol Methods.
1983;65(1–2):55–63.
15. Choi CW, Choi YH, Cha MR, Yoo DS, Kim YS, Yon GH, et al. Yeast alpha-
glucosidase inhibition by isoflavones from plants of Leguminosae as an
in vitro alternative to acarbose. J Agric Food Chem. 2010;58(18):9988–93.
16. Keller AC, Ma J, Kavalier A, He K, Brillantes AM, Kennelly EJ. Saponins from
the traditional medicinal plant Momordica charantia stimulate insulin
secretion in vitro. Phytomedicine. 2011;19(1):32–7.
17. Sacchetti G, Maietti S, Muzzoli M, Scaglianti M, Manfredini S, Radice M, et al.
Comparative evaluation of 11 essential oils of different origin as functional
Kumkrai et al. BMC Complementary and Alternative Medicine  (2015) 15:35 Page 10 of 10antioxidants, antiradicals and antimicrobials in foods. Food Chem.
2005;91(4):621–32.
18. Imeh U, Khokhar S. Distribution of conjugated and free phenols in
fruits: antioxidant activity and cultivar variations. J Agric Food Chem.
2002;50(22):6301–6.
19. Parr A, Bolwell G. Phenols in the plant and in man. The potential for
possible nutritional enhancement of the diet by modifying the phenols
content or profile. J Sci Food Agric. 2000;80(7):985–1012.
20. Middleton Jr E, Kandaswami C, Theoharides TC. The effects of plant
flavonoids on mammalian cells: implications for inflammation, heart disease,
and cancer. Pharmacol Rev. 2000;52(4):673–751.
21. Velioglu YS, Mazza G, Gao L, Oomah BD. Antioxidant activity and total
phenolics in selected fruits, vegetables, and grain products. J Agric Food
Chem. 1998;46(10):4113–7.
22. Misbah H, Aziz AA, Aminudin N. Antidiabetic and antioxidant properties of
Ficus deltoidea fruit extracts and fractions. BMC Complement Altern Med.
2013;13:118.
23. Chivapat S, Chavalittumrong P, Attawish A, Soonthornchareonnon N.
Toxicity study of lupinifolin from stem of Derris reticulata Craib. J Thai Tradit
Altern Med. 2009;7(2–3):146–55.
24. Mahidol C, Prawat H, Ruchirawat S, Lihkitwitayawuid K, Lin L-Z,
Cordell GA. Prenylated flavanones from Derris reticulata. Phytochemistry.
1997;45(4):825–9.
25. Ranga Rao R, Tiwari AK, Prabhakar Reddy P, Suresh Babu K, Ali AZ,
Madhusudana K, et al. New furanoflavanoids, intestinal alpha-glucosidase
inhibitory and free-radical (DPPH) scavenging, activity from antihyperglycemic
root extract of Derris indica (Lam.). Bioorg Med Chem. 2009;17(14):5170–5.
26. Chiu HL, Wu JH, Tung YT, Lee TH, Chien SC, Kuo YH. Triterpenoids and
aromatics from Derris laxiflora. J Natl Prod. 2008;71(11):1829–32.
27. Rao SA, Srinivas PV, Tiwari AK, Vanka UM, Rao RV, Dasari KR, et al. Isolation,
characterization and chemobiological quantification of alpha-glucosidase
enzyme inhibitory and free radical scavenging constituents from Derris
scandens Benth. J Chromatogr B Analyt Technol Biomed Life Sci.
2007;855(2):166–72.
28. Mahabusarakam W, Deachathai S, Phongpaichit S, Jansakul C, Taylor WC.
A benzil and isoflavone derivatives from Derris scandens Benth.
Phytochemistry. 2004;65(8):1185–91.
29. Quezada N, Asencio M, del Valle JM, Aguilera JM, Gomez B. Antioxidant
activity of crude extract, alkaloid fraction, and flavonoid fraction from boldo
(Peumus boldus Molina) leaves. J Food Sci. 2004;69(5):C371–6.
30. Zhang L, Yang J, Chen XQ, Zan K, Wen XD, Chen H, et al. Antidiabetic and
antioxidant effects of extracts from Potentilla discolor Bunge on diabetic
rats induced by high fat diet and streptozotocin. J Ethnopharmacol.
2010;132(2):518–24.
31. Kiranmai M, Kumar CM, Ibrahim M. Comparison of total flavanoid content of
Azadirachta indica root bark extracts prepared by different methods of
extraction. Res J Pharm Biol Chem Sci. 2011;2:254–61.
32. Gandhi GR, Ignacimuthu S, Paulraj MG. Solanum torvum Swartz. fruit
containing phenolic compounds shows antidiabetic and antioxidant
effects in streptozotocin induced diabetic rats. Food Chem Toxicol.
2011;49(11):2725–33.
33. Frode TS, Medeiros YS. Animal models to test drugs with potential
antidiabetic activity. J Ethnopharmacol. 2008;115(2):173–83.
34. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes.
Diabetologia. 2008;51(2):216–26.
35. Si MM, Lou JS, Zhou CX, Shen JN, Wu HH, Yang B, et al. Insulin releasing
and alpha-glucosidase inhibitory activity of ethyl acetate fraction of Acorus
calamus in vitro and in vivo. J Ethnopharmacol. 2010;128(1):154–9.
36. Olaokun OO, McGaw LJ, Eloff JN, Naidoo V. Evaluation of the inhibition of
carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic
content of extracts of ten African Ficus species (Moraceae) used traditionally
to treat diabetes. BMC Complement Altern Med. 2013;13:94.
37. Bothon FT, Debiton E, Avlessi F, Forestier C, Teulade JC, Sohounhloue DK.
In vitro biological effects of two anti-diabetic medicinal plants used in Benin
as folk medicine. BMC Complement Altern Med. 2013;13:51.
38. Nolte Kenedy MS. From Pancretic hormones and antidiabetic drugs. In:
Katzung BG, Master SB, Trevor AJ, editors. Basic and Clinical Pharmacology.
12th ed. Singapore: The McGraw-Hill Companies; 2012. p. 743–68.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
